P2RY12 and myocardial infarction: In India, as few as 48% of patients admitted for ST elevated myocardial infarction received any form of reperfusion therapy, while the proportion of ACS patients prescribed P2Y12 inhibitor, statin, betablocker or ACEI/ARB on discharge was 79.4%, 70.1%, 62.7% and 25.5%, respectively17.